PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus® in Type 1 Diabetes Mellitus Patients
Clinical trial NCT04236895 · COMPLETED
Trial details
- NCT number
- NCT04236895
- Sponsor
- Gan and Lee Pharmaceuticals, USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2018-11-28
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.